SAN DIEGO, Feb. 17 /PRNewswire-FirstCall/ -- Hollis-Eden Pharmaceuticals, Inc. (NASDAQ:HEPH), today announced that it has changed its name to...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
Table of Contents As filed with the Securities and Exchange Commission on January 6, 2010 Registration No. 333-163936 ...
Table of Contents As filed with the Securities and Exchange Commission on December 22, 2009 Registration No. 333- &nbs...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR...
BOSTON, Nov. 16 /PRNewswire-FirstCall/ -- Hollis-Eden Pharmaceuticals, Inc. (NASDAQ:HEPH), today reported preliminary results of its ongoing...
- Company Provides Update on Progress of Lead Compounds - SAN DIEGO, Nov. 12 /PRNewswire-FirstCall/ -- Hollis-Eden Pharmaceuticals, Inc...
Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) x QUARTERLY REPORT...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.